Is INDV a good stock to buy? We came across a bullish thesis on Indivior Pharmaceuticals, Inc. on The Mispricing Desk’s Substack. In this article, we will summarize the bulls’ thesis on INDV. Indivior Pharmaceuticals, Inc.'s share was trading at $37.39 as of June 8th. INDV’s trailing and forward P/E were 19.30 and 12.27 respectively according to Yahoo Finance.
[caption id="attachment_514321" align="aligncenter" width="750"]Indivior (INDV) is a specialty pharmaceutical company anchored by its SUBLOCADE franchise, which...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.